TAK-220, a Novel Small-Molecule CCR5 Antagonist, Has Favorable Anti-Human Immunodeficiency Virus Interactions with Other Antiretrovirals In Vitro

TAK-220 is a CCR5 antagonist, part of the new class of anti-human immunodeficiency virus type 1 (anti-HIV-1) entry inhibitors. We evaluated the anti-HIV-1 interactions between TAK-220 and various antiretrovirals in vitro. Synergy was observed with all drugs at the 90 and 95% inhibitory concentration...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Tremblay, Cécile L., Giguel, Françoise, Guan, Yongbiao, Chou, Ting-Chao, Takashima, Katsunori, Hirsch, Martin S.
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: American Society for Microbiology 2005
Konular:
Antiviral Agents
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1196290/
https://ncbi.nlm.nih.gov/pubmed/16048964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.8.3483-3485.2005
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC1196290/
https://ncbi.nlm.nih.gov/pubmed/16048964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.8.3483-3485.2005

Benzer Materyaller